(Q28729196)

English

Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis

scientific article (publication date: 2012)

In more languages

Statements

scholarly article

0 references

Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis (English)

0 references

0 references

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

6

0 references

Ron T Gansevoort

5

object named as

Ron T Gansevoort

0 references

author name string

Martin H de Borst

1

0 references

Ferdau L Nauta

2

0 references

Liffert Vogt

3

0 references

Gozewijn D Laverman

4

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

5

0 references

e37957

0 references

copyright license

Creative Commons Attribution 4.0 International

25 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Glomerular and tubular damage markers are elevated in patients with diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Time for a comeback of NSAIDs in proteinuric chronic kidney disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Benefits of dietary sodium restriction in the management of chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Renal toxicity of therapeutic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Effects of nonsteroidal anti-inflammatory drugs on proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Nonsteroidal anti-inflammatory drugs: effects on kidney function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Treatment of the nephrotic syndrome with indomethacin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360674

3 June 2018

Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Effect of high dose ramipril with or without indomethacin on glomerular selectivity

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037957

21 January 2018

Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal survival in membranoproliferative glomerulonephritis (MPGN): role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: A clue to the mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen

1 reference

https://pubmed.ncbi.nlm.nih.gov/22662255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0037957

0 references

2012PLoSO...737957D

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28729196&oldid=2006855308"